aTyr Pharma, Inc.
ATYR
$4.06
$0.0651.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.99M | 78.48M | 84.50M | 98.17M | 102.13M |
| Total Receivables | 1.83M | 1.63M | 2.48M | 2.44M | 2.09M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.50M | 10.19M | 9.94M | 2.39M | 3.08M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 76.32M | 90.30M | 96.92M | 102.99M | 107.30M |
|
|
|||||
| Total Current Assets | 76.32M | 90.30M | 96.92M | 102.99M | 107.30M |
| Net Property, Plant & Equipment | 12.24M | 12.62M | 12.99M | 14.05M | 14.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.06M | 3.03M | 3.34M | 3.62M | 3.52M |
| Total Assets | 91.62M | 105.94M | 113.25M | 120.65M | 125.07M |
|
|
|||||
| Total Accounts Payable | 3.95M | 1.26M | 4.89M | 3.53M | 2.04M |
| Total Accrued Expenses | 8.96M | 9.41M | 9.95M | 11.56M | 9.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.21M | 1.17M | 1.14M | 1.33M | 1.23M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.12M | 11.84M | 15.98M | 16.42M | 12.88M |
|
|
|||||
| Total Current Liabilities | 14.12M | 11.84M | 15.98M | 16.42M | 12.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.36M | 12.68M | 12.99M | 13.77M | 13.99M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.48M | 24.52M | 28.97M | 30.18M | 26.87M |
|
|
|||||
| Common Stock & APIC | 582.37M | 581.60M | 568.14M | 558.76M | 551.95M |
| Retained Earnings | -517.08M | -499.82M | -483.51M | -468.02M | -453.26M |
| Treasury Stock & Other | 36.00K | -168.00K | -158.00K | -74.00K | -294.00K |
| Total Common Equity | 65.33M | 81.61M | 84.47M | 90.66M | 98.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 65.33M | 81.61M | 84.47M | 90.66M | 98.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -186.00K | -184.00K | -184.00K | -188.00K | -187.00K |
| Total Equity | 65.14M | 81.42M | 84.28M | 90.47M | 98.20M |
|
|
|||||
